Ido Bachelet

Ido Bachelet
Nationality Israeli
Fields Bio-inspired engineering, DNA origami, Nanorobotics
Institutions Rehovot Science Park, Israel
Alma mater Massachusetts Institute of Technology, Harvard University, Hebrew University
Doctoral advisor Prof. Francesca Levi-Schaffer
Other academic advisors George Church
Notable students None notable

Ido Bachelet is an Israeli musician[1] and scientist. Formerly a principal investigator at Bar-Ilan University, he is currently an independent scientist and inventor.

Education

Dr. Bachelet earned his Ph.D. from the Hebrew University in Jerusalem, where he performed research under the supervision of Prof. Francesca Levi-Schaffer.[2][3][4][5] Was a postdoctoral fellow in engineering at M.I.T. and later at Harvard University in immunomics and DNA nanotechnology at the George Church lab.[6] Formerly an assistant professor in the Faculty of Life Sciences and the Nano-Center at Bar Ilan University, Israel, he has gone independent in 2015. Bachelet is the founder of several companies, such as the computer vision company Sight Diagnostics .

Research

Bachelet is known for his contribution to the fields of DNA origami, Nanotechnology, and Nanorobotics. His well cited[7] paper "A logic-gated nanorobot for targeted transport of molecular payloads",[8] which deals with nano robots being able to kill cancer cells, created an important interface between the field of DNA origami and medicine.

References

  1. ↑ http://www.mako.co.il/news-israel/entertainment-q3_2014/Article-e4a11fe3fd66841004.htm
  2. ↑ Bachelet, I., Munitz, A., Moretta, A., Moretta, L. and Levi-Schaffer, F. (2005) The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J. Immunol. 175:7989-7995.
  3. ↑ Bachelet, I., Munitz, A. and Levi-Schaffer, F. (2006) Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a. J. Allergy Clin. Immunol 117:1314-1320.
  4. ↑ Bachelet, I., Munitz, A., Mankuta, D. and Levi-Schaffer, F. (2006) Mast cell costimulation by CD226/CD112 (DNAM-1/Nectin-2): A novel interface in the allergic process. J. Biol. Chem. 281:27190-27196
  5. ↑ Bachelet, I., Munitz, A., Berent-Maoz, B., Mankuta, D., Levi-Schaffer, F. (2008) Suppression of normal and malignant Kit signaling by a bispecific antibody linking Kit with CD300a. J. Immunology 180:6064-6069.
  6. ↑ Douglas, S. M., Bachelet, I. & Church, G. M. A logic-gated nanorobot for targeted transport of molecular payloads. Science 335, 831–834 (2012).
  7. ↑ https://www.google.co.il/?gfe_rd=cr&ei=gltUVcuxOKfD8gf1_ID4CA&gws_rd=ssl#q=A+Logic-Gated+Nanorobot+for+Targeted+Transport+of+Molecular+Payloads
  8. ↑ Douglas, S. M., Bachelet, I. & Church, G. M. A logic-gated nanorobot for targeted transport of molecular payloads. Science 335, 831–834 (2012).

External links

This article is issued from Wikipedia - version of the 8/18/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.